{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:59:24Z","timestamp":1791575964562,"version":"4.3.4"},"reference-count":218,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cpt.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:47:31Z","timestamp":1744051651000},"page":"81-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Arthropod venom peptides: Nanotechnology-enabled delivery and therapeutic potential in cancer treatment"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0457-9723","authenticated-orcid":false,"given":"Sara K.","family":"Ghodeif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"El-Fahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-6997","authenticated-orcid":false,"given":"Nahla S.","family":"El-Shenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2025.03.005_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056722","article-title":"Infection-related and lifestyle-related cancer burden in Kampala, Uganda: projection of the future cancer incidence up to 2030","volume":"12","author":"Asasira","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpt.2025.03.005_bib2","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.cpt.2025.03.005_bib3","article-title":"Use of animal venom peptides\/toxins in cancer","volume":"16","author":"Upadhyay","year":"2018","journal-title":"Curr Trends Biomedical Eng & Biosci"},{"key":"10.1016\/j.cpt.2025.03.005_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10059-011-0051-5","article-title":"Nanomaterials for cancer therapy and imaging","volume":"31","author":"Bae","year":"2011","journal-title":"Mol-Cells"},{"key":"10.1016\/j.cpt.2025.03.005_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.drudis.2020.12.021","article-title":"From venom to drugs: a review and critical analysis of Indian snake venom toxins envisaged as anticancer drug prototypes","volume":"26","author":"Kalita","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cpt.2025.03.005_bib6","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2025.03.005_bib7","article-title":"Botanical Sources, pharmacokinetics, and therapeutic efficacy of palmatine and its derivatives in the management of cancer: a comprehensive mechanistic analysis","volume":"2024","author":"Oni","year":"2024","journal-title":"J Food Biochem"},{"key":"10.1016\/j.cpt.2025.03.005_bib8","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jnci\/djab131","article-title":"Annual report to the nation on the status of cancer, part 1: national cancer statistics","volume":"113","author":"Islami","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpt.2025.03.005_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5306\/wjco.v7.i1.54","article-title":"Historical review of the causes of cancer","volume":"7","author":"Blackadar","year":"2016","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.cpt.2025.03.005_bib10","first-page":"3121","article-title":"Cancer causes and treatments","volume":"11","author":"Saini","year":"2020","journal-title":"Int J Pharm Sci Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib11","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/v14081704","article-title":"The viral origin of human breast cancer: from the mouse mammary tumor virus (MMTV) to the human Betaretrovirus (HBRV)","volume":"14","author":"Bevilacqua","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cpt.2025.03.005_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cpt.2025.03.005_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cpt.2025.03.005_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons learned from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cpt.2025.03.005_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J Contr Release"},{"key":"10.1016\/j.cpt.2025.03.005_bib16","first-page":"69","article-title":"Recent application of nanotechnology for cancer immunotherapy and its future prospects","volume":"10","author":"Akabari","year":"2023","journal-title":"Int J Immunol Immunother"},{"key":"10.1016\/j.cpt.2025.03.005_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"Sage Open Med"},{"key":"10.1016\/j.cpt.2025.03.005_bib18","first-page":"1","article-title":"African plant-based products as a source of potent drugs to overcome cancers and their chemoresistance: part 1. Cancer chemoresistance, screening methods, and the updated cut-off points for the classification of natural cytotoxic products","volume":"111","author":"Jacquot","year":"2024","journal-title":"Amesterdam: Elsevier"},{"key":"10.1016\/j.cpt.2025.03.005_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cpt.2025.03.005_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2017.1335567","article-title":"Possible role of nanocarriers in drug delivery against cervical cancer","volume":"8","author":"Gupta","year":"2017","journal-title":"Nano Rev Exp"},{"key":"10.1016\/j.cpt.2025.03.005_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i5.20","article-title":"Polymeric micelles for delivery of poorly water-soluble compounds","volume":"20","author":"Kwon","year":"2003","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.cpt.2025.03.005_bib22","first-page":"95","article-title":"Cellular mechanisms of multidrug resistance of tumor cells","volume":"65","author":"Stavrovskaya","year":"2000","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.cpt.2025.03.005_bib23","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.3390\/molecules28093671","article-title":"Anticancer potentials of the lignan magnolin: a systematic review","volume":"28","author":"Bhuia","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/ijmpo.ijmpo_200_17","article-title":"Study of the use of traditional, complementary, and alternative medicine in Indian cancer patients","volume":"40","author":"Shetty","year":"2019","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.cpt.2025.03.005_bib25","series-title":"New approaches to natural anticancer drugs","author":"Saeidnia","year":"2015"},{"key":"10.1016\/j.cpt.2025.03.005_bib26","first-page":"109","article-title":"Medicinal plants as a potential source of chemopreventive agents","author":"Roy","year":"2018","journal-title":"Anticancer plants: natural products and biotechnological implements"},{"key":"10.1016\/j.cpt.2025.03.005_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/toxins11020075","article-title":"Malaysian cobra venom: a potential source of anti-cancer therapeutic agents","volume":"11","author":"Zainal Abidin","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib28","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1111\/jcmm.13745","article-title":"Triggering of cancer cell cycle arrest by a novel scorpion venom-derived peptide\u2014gonearrestide","volume":"22","author":"Li","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cpt.2025.03.005_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40409-015-0042-7","article-title":"Arthropod venom hyaluronidases: Biochemical properties and potential applications in medicine and biotechnology","volume":"21","author":"Bordon","year":"2015","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.cpt.2025.03.005_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bip.22748","article-title":"Chlorotoxin: structure, activity, and potential uses in cancer therapy","volume":"106","author":"Ojeda","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.cpt.2025.03.005_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/1535-7163.MCT-23-0256","article-title":"Targeting dysregulated ion channels in liver tumors with venom peptides","volume":"23","author":"Achimba","year":"2024","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.cpt.2025.03.005_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264093","article-title":"Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells","volume":"17","author":"Alhakamy","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.005_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.01.002","article-title":"Arthropod venoms and cancer","volume":"57","author":"Heinen","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib34","first-page":"1","article-title":"A preliminary research of the antineoplastic effects induced by Buthus martensii of Chinese drug-I","volume":"6","author":"Zhang","year":"1987","journal-title":"J Gannan Med Coll"},{"key":"10.1016\/j.cpt.2025.03.005_bib35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.cpt.2025.03.005_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.cpt.2025.03.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-004-4205-6","article-title":"Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro","volume":"73","author":"Wang","year":"2005","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.cpt.2025.03.005_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24152778","article-title":"Hypotensive snake venom components-A mini-review","volume":"24","author":"P\u00e9terfi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.crtox.2021.09.001","article-title":"Venom peptides - a comprehensive translational perspective in pain management","volume":"2","author":"V","year":"2021","journal-title":"Curr Res Toxicol"},{"key":"10.1016\/j.cpt.2025.03.005_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2018.11.433","article-title":"Arthropod venoms: biochemistry, ecology and evolution","volume":"158","author":"Laxme","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/toxins12020082","article-title":"Arthropod venom components and their potential usage","volume":"12","author":"R\u00e1dis-Baptista","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cpt.2025.03.005_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/toxins11070427","article-title":"Pain and lethality induced by insect stings: an exploratory and correlational study","volume":"11","author":"Schmidt","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cpt.2025.03.005_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2014.06.006","article-title":"Antimicrobial peptides from scorpion venoms","volume":"88","author":"Harrison","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10989-019-09932-1","article-title":"Cytotoxic effects of Smp24 and Smp43 scorpion venom antimicrobial peptides on tumor and non-tumor cell lines","volume":"26","author":"Elrayess","year":"2020","journal-title":"Int J Pept Res Therapeut"},{"key":"10.1016\/j.cpt.2025.03.005_bib45","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.peptides.2003.08.023","article-title":"The relationship between peptide structure and antibacterial activity","volume":"24","author":"Powers","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.cpt.2025.03.005_bib46","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/molecules25122850","article-title":"Antimicrobial peptides as anticancer agents: functional properties and biological activities","volume":"25","author":"Tornesello","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/toxins14070438","article-title":"Scorpion peptide Smp24 exhibits a potent antitumor effect on human lung cancer cells by damaging the membrane and cytoskeleton in vivo and in vitro","volume":"14","author":"Guo","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2017.08.012","article-title":"Phosphatidylserine: a cancer cell targeting biomarker","volume":"52","author":"Sharma","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cpt.2025.03.005_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2018.01.133","article-title":"RK1, the first very short peptide from Buthus occitanus tunetanus inhibits tumor cell migration, proliferation and angiogenesis","volume":"499","author":"Khamessi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cpt.2025.03.005_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10989-023-10494-6","article-title":"Scorpion venom peptide smp24 revealed apoptotic and antiangiogenic activities in solid-Ehrlich carcinoma bearing mice","volume":"29","author":"Fawzy","year":"2023","journal-title":"Int J Pept Res Therapeut"},{"key":"10.1016\/j.cpt.2025.03.005_bib51","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1124\/mol.65.3.630","article-title":"Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro","volume":"65","author":"J\u00e4ger","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.005_bib52","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425247.4.2.175","article-title":"Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)","volume":"4","author":"Mamelak","year":"2007","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.cpt.2025.03.005_bib54","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood-2006-06-029934","article-title":"Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis","volume":"109","author":"Arbiser","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2025.03.005_bib55","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.162.9.5624","article-title":"Down-regulation of human basophil IgE and FC\u03b5RI\u03b1 surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo","volume":"162","author":"Saini","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cpt.2025.03.005_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108270","article-title":"Emerging therapeutic applications of scorpion venom peptides in the Middle East and North Africa: a comprehensive review","volume":"256","author":"Lafnoune","year":"2025","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/toxins15050347","article-title":"The potent antitumor activity of Smp43 against non-small-cell lung cancer A549 cells via inducing membranolysis and mitochondrial dysfunction","volume":"15","author":"Deng","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxicon.2016.03.014","article-title":"Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus","volume":"117","author":"Harrison","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00726-009-0449-y","article-title":"Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index","volume":"40","author":"Rodr\u00edguez","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.cpt.2025.03.005_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(91)80402-O","article-title":"Contribution of proline-14 to the structure and actions of melittin","volume":"281","author":"Dempsey","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cpt.2025.03.005_bib61","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/protein\/9.12.1219","article-title":"Specific antimicrobial and hemolytic activities of 18-residue peptides derived from the amino terminal region of the toxin pardaxin","volume":"9","author":"Thennarasu","year":"1996","journal-title":"Protein Eng"},{"key":"10.1016\/j.cpt.2025.03.005_bib62","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/bi962507l","article-title":"Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure\u2212 function study","volume":"36","author":"Oren","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.cpt.2025.03.005_bib63","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/1061186X.2013.837469","article-title":"Nanotechnology in cancer therapy","volume":"21","author":"Aslan","year":"2013","journal-title":"J Drug Target"},{"key":"10.1016\/j.cpt.2025.03.005_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cpt.2025.03.005_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/ab500084g","article-title":"Nanotherapy for cancer: targeting and multifunctionality in the future of cancer therapies","volume":"1","author":"Ediriwickrema","year":"2015","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.cpt.2025.03.005_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/cancers15010162","article-title":"Nanoparticles and nanomaterials-based recent approaches in upgraded targeting and management of cancer: a review","volume":"15","author":"Ojha","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.03.005_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213903","article-title":"Unlocking nature's arsenal: nanotechnology for targeted delivery of venom toxins in cancer therapy","volume":"162","author":"Chary","year":"2024","journal-title":"Biomater Adv"},{"key":"10.1016\/j.cpt.2025.03.005_bib68","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1021\/nn800716j","article-title":"Composite nanoparticles take aim at cancer","volume":"2","author":"Gil","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.cpt.2025.03.005_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/751075","article-title":"Noble metal nanoparticles applications in cancer","volume":"2012","author":"Conde","year":"2012","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.cpt.2025.03.005_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cancers14030622","article-title":"Targeted delivery methods for anticancer drugs","volume":"14","author":"Veselov","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.03.005_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112951","article-title":"Biomedical applications of metallic nanoparticles in cancer: current status and future perspectives","volume":"150","author":"Khursheed","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpt.2025.03.005_bib72","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/ijms13021951","article-title":"Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design","volume":"13","author":"Diaz-Cano","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib73","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/ijms17050769","article-title":"Polymeric nanoparticle-based photodynamic therapy for chronic periodontitis in vivo","volume":"17","author":"De Freitas","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib74","article-title":"Plasmonic photothermal nanoparticles for biomedical applications","volume":"6","author":"Kim","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cpt.2025.03.005_bib75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1039\/C7CS00807D","article-title":"Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control","volume":"48","author":"Liu","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cpt.2025.03.005_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118322","article-title":"Fabrication of a multi-level drug release platform with liposomes, chitooligosaccharides, phospholipids and injectable chitosan hydrogel to enhance anti-tumor effectiveness","volume":"269","author":"Li","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cpt.2025.03.005_bib77","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J Personalized Med"},{"key":"10.1016\/j.cpt.2025.03.005_bib78","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumor sites","volume":"71","author":"Attia","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.005_bib79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cpt.2025.03.005_bib80","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2174\/1381612825666190425163424","article-title":"Alginate nanoparticles for drug delivery and targeting","volume":"25","author":"Severino","year":"2019","journal-title":"Curr pharm Des"},{"key":"10.1016\/j.cpt.2025.03.005_bib81","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cpt.2025.03.005_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/pharmaceutics11010022","article-title":"Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems","volume":"11","author":"Silva","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib83","article-title":"Green synthesis of silver nanoparticles via various plant extracts for anti-cancer applications","volume":"2","author":"Singh","year":"2017","journal-title":"Glob J Nanomedicine"},{"key":"10.1016\/j.cpt.2025.03.005_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11121-3","article-title":"Bio-fabrication of silver nanoparticles by phycocyanin, characterization, in vitro anticancer activity against breast cancer cell line and in vivo cytotxicity","volume":"7","author":"El-Naggar","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.03.005_bib85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1259\/bjr\/59448833","article-title":"Gold nanoparticles as novel agents for cancer therapy","volume":"85","author":"Jain","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cpt.2025.03.005_bib86","first-page":"119","article-title":"Copper nanoparticles as therapeutic anticancer agents","volume":"2","author":"Halevas","year":"2018","journal-title":"Nanomed Nanotechnol J"},{"key":"10.1016\/j.cpt.2025.03.005_bib87","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1039\/D0TB00739K","article-title":"Zinc oxide nanoparticles for therapeutic purposes in cancer medicine","volume":"8","author":"Wiesmann","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cpt.2025.03.005_bib88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12951-021-00902-8","article-title":"Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies","volume":"19","author":"Cui","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cpt.2025.03.005_bib89","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab56b6","article-title":"Green synthesis of near-infrared absorbing eugenate capped iron oxide nanoparticles for photothermal application","volume":"31","author":"Kharey","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.cpt.2025.03.005_bib90","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/pharmaceutics15102406","article-title":"Iron oxide nanoparticles in cancer treatment: cell responses and the potency to improve radiosensitivity","volume":"15","author":"Shestovskaya","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11051-023-05813-3","article-title":"Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment","volume":"25","author":"Thapa","year":"2023","journal-title":"J Nanopart Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119763","article-title":"Chitosan nanoparticles for oral photothermally enhanced photodynamic therapy of colon cancer","volume":"589","author":"Chen","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cpt.2025.03.005_bib93","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","article-title":"Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer","volume":"30","author":"Malam","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-22942-3_3","article-title":"Polymeric nanoparticles for cancer photodynamic therapy","volume":"370","author":"Conte","year":"2016","journal-title":"Top Curr Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2021.09.024","article-title":"Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system","volume":"339","author":"Moghassemi","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.cpt.2025.03.005_bib96","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/pharmaceutics13122000","article-title":"Protein-based nanoparticles for the imaging and treatment of solid tumors: the case of ferritin nanocages, a narrative review","volume":"13","author":"Mainini","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib97","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/polym10101133","article-title":"Hyaluronic acid-based nanomaterials for cancer therapy","volume":"10","author":"Kim","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.cpt.2025.03.005_bib98","doi-asserted-by":"crossref","DOI":"10.1063\/5.0127835","article-title":"Advances in imaging and treatment of atherosclerosis based on organic nanoparticles","volume":"6","author":"Tu","year":"2022","journal-title":"APL Bioeng"},{"key":"10.1016\/j.cpt.2025.03.005_bib99","first-page":"14","article-title":"Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review","author":"Ibrahim","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ifset.2007.05.001","article-title":"Phospholipid nanovesicles containing a bacteriocin-like substance for control of Listeria monocytogenes","volume":"9","author":"Teixeira","year":"2008","journal-title":"Innov Food Sci Emerg Technol"},{"key":"10.1016\/j.cpt.2025.03.005_bib101","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.micron.2007.06.013","article-title":"Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting","volume":"38","author":"Colas","year":"2007","journal-title":"Micron"},{"key":"10.1016\/j.cpt.2025.03.005_bib102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1745-4565.2008.00113.x","article-title":"Listeria monocytogenes and Escherichia coli O157: H7 inhibition in vitro by liposome-encapsulated nisin and ethylene diaminetetraacetic acid","volume":"28","author":"Taylor","year":"2008","journal-title":"J Food Saf"},{"key":"10.1016\/j.cpt.2025.03.005_bib103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0958-6946(02)00194-2","article-title":"Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation","volume":"13","author":"Laridi","year":"2003","journal-title":"Int Dairy J"},{"key":"10.1016\/j.cpt.2025.03.005_bib104","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/acs.bioconjchem.6b00677","article-title":"Strategies for the activation and release of the membranolytic peptide melittin from liposomes using endosomal pH as a trigger","volume":"28","author":"Oude Blenke","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2021.106890","article-title":"Essential contributions of food hydrocolloids and phospholipid liposomes to the formation of carriers for controlled delivery of biologically active substances via the gastrointestinal tract","volume":"120","author":"Semenova","year":"2021","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.cpt.2025.03.005_bib106","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2174\/0929867328666210813154019","article-title":"Mucoadhesive nanosystems for nose-to-brain drug delivery in the treatment of central nervous system diseases","volume":"29","author":"Di Filippo","year":"2022","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib107","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/IJN.S123514","article-title":"In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach","volume":"12","author":"Al-Asmari","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.cpt.2025.03.005_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925985","article-title":"CAR T-cell-based gene therapy for cancers: new perspectives, challenges, and clinical developments","volume":"13","author":"Jogalekar","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2025.03.005_bib109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1567201817666200512104441","article-title":"Lipid-coated nanosized drug delivery systems for an effective cancer therapy","volume":"18","author":"Esim","year":"2021","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.cpt.2025.03.005_bib110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/pharmaceutics13081235","article-title":"Hyaluronic acid coating reduces the leakage of melittin encapsulated in liposomes and increases targeted delivery to melanoma cells","volume":"13","author":"Li","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib111","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/biom12010118","article-title":"Melittin-based nano-delivery systems for cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib112","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1166\/jbn.2016.2228","article-title":"Functional chitosan nanoparticles in cancer treatment","volume":"12","author":"Fu","year":"2016","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.cpt.2025.03.005_bib113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib114","first-page":"1","article-title":"Chitosan-based nanogel enhances chemotherapeutic efficacy of 10-hydroxycamptothecin against human breast cancer cells","volume":"2019","author":"Guo","year":"2019","journal-title":"Int J Polym Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib115","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.3390\/ijms20225776","article-title":"Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles","volume":"20","author":"Rizeq","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118050","article-title":"Immunostimulatory effect of chitosan and quaternary chitosan: a review of potential vaccine adjuvants","volume":"264","author":"Li","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cpt.2025.03.005_bib117","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/pharmaceutics14050891","article-title":"Nanobiotechnology with therapeutically relevant macromolecules from animal venoms: venoms, toxins, and antimicrobial peptides","volume":"14","author":"Roque-Borda","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118464","article-title":"Chitosan-based nanodelivery systems for cancer therapy: recent advances","volume":"272","author":"Narmani","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cpt.2025.03.005_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272776","article-title":"Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK\/ERK pathway","volume":"17","author":"Abdulmalek","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.005_bib120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/polym16020206","article-title":"Degradable polymeric bio(nano) materials and their biomedical applications: a comprehensive overview and recent updates","volume":"16","author":"Kuperkar","year":"2024","journal-title":"Polymers"},{"key":"10.1016\/j.cpt.2025.03.005_bib121","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nantod.2009.06.013","article-title":"Synthesis and biomedical applications of hollow nanostructures","volume":"4","author":"An","year":"2009","journal-title":"Nano Today"},{"key":"10.1016\/j.cpt.2025.03.005_bib122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.msec.2015.11.023","article-title":"Polymer\/metal nanocomposites for biomedical applications","volume":"60","author":"Zare","year":"2016","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.cpt.2025.03.005_bib123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/nano6110209","article-title":"Green synthesis of iron nanoparticles and their environmental applications and implications","volume":"6","author":"Saif","year":"2016","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.cpt.2025.03.005_bib124","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2217\/nnm-2017-0320","article-title":"Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery","volume":"13","author":"El-Boubbou","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.cpt.2025.03.005_bib125","article-title":"Nanoparticles-mediated combination therapies for cancer treatment","volume":"2","author":"Shrestha","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.cpt.2025.03.005_bib126","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.39915","article-title":"Nanoparticle-based cell trackers for biomedical applications","volume":"10","author":"Ni","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cpt.2025.03.005_bib127","article-title":"External and internal stimuli-responsive metallic nanotherapeutics for enhanced anticancer therapy","volume":"7","author":"Mohapatra","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cpt.2025.03.005_bib128","article-title":"EGFR targeting for cancer therapy: pharmacology and immunoconjugates with drugs and nanoparticles","volume":"592","author":"da Silva Santos","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cpt.2025.03.005_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100136","article-title":"Tumor vasculature vs tumor cell targeting: understanding the latest trends in using functional nanoparticles for cancer treatment","volume":"11","author":"Awad","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.cpt.2025.03.005_bib130","first-page":"9","article-title":"A review on nanoparticles: their synthesis and types","volume":"4","author":"Hasan","year":"2015","journal-title":"Res J Recent Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib131","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12011-020-02138-3","article-title":"Green synthesis of metallic nanoparticles and their prospective biotechnological applications: an overview","volume":"199","author":"Salem","year":"2021","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib132","article-title":"Recent advances in green synthesized nanoparticles: from production to application","volume":"24","author":"Hosseingholian","year":"2023","journal-title":"Materials Today Sustainability"},{"key":"10.1016\/j.cpt.2025.03.005_bib133","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/nano14171425","article-title":"Silver nanoparticles: synthesis, structure, properties and applications","volume":"14","author":"Abbas","year":"2024","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.cpt.2025.03.005_bib134","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1742-1241.2006.01196.x","article-title":"Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data","volume":"60","author":"Gallwitz","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cpt.2025.03.005_bib135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13238-010-0004-3","article-title":"Alpha-helical cationic antimicrobial peptides: relationships of structure and function","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.cpt.2025.03.005_bib136","first-page":"267","article-title":"Proteins and peptides as anticancer agents","author":"Panda","year":"2012","journal-title":"Bioactive food and peptides"},{"key":"10.1016\/j.cpt.2025.03.005_bib137","first-page":"15","article-title":"Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential","volume":"3","author":"Biswas","year":"2012","journal-title":"J Venom Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43094-022-00415-7","article-title":"Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations","volume":"8","author":"Joglekar","year":"2022","journal-title":"Future J Pharm Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib139","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/jfb13040278","article-title":"Delivery of melittin as a lytic agent via graphene nanoparticles as carriers to breast cancer cells","volume":"13","author":"Daniluk","year":"2022","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.cpt.2025.03.005_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264093","article-title":"Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells","volume":"17","author":"Alhakamy","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.005_bib141","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.7150\/thno.19780","article-title":"Spider toxin peptide lycosin-I functionalized gold nanoparticles for in vivo tumor targeting and therapy","volume":"7","author":"Tan","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.cpt.2025.03.005_bib142","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/pharmaceutics13122144","article-title":"Phyto-phospholipid conjugated scorpion venom nanovesicles as promising carrier that improves efficacy of thymoquinone against adenocarcinoma human alveolar basal epithelial cells","volume":"13","author":"Asfour","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.005_bib143","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.biomaterials.2010.11.079","article-title":"Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.cpt.2025.03.005_bib144","series-title":"Venoms of the hymenoptera: biochemical, pharmacological and behavioural aspects","first-page":"329","article-title":"Chemistry and pharmacology of honey-bee venom","author":"Banks","year":"1986"},{"key":"10.1016\/j.cpt.2025.03.005_bib145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/molecules24050929","article-title":"Bee venom and its peptide component melittin suppress growth and migration of melanoma cells via inhibition of PI3K\/AKT\/mTOR and MAPK pathways","volume":"24","author":"Lim","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib146","first-page":"931","article-title":"The anti-tumor effect of Mel and its role in autophagy in human hepatocellular carcinoma cells","volume":"11","author":"Lv","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib147","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0304-4165(77)90106-4","article-title":"Melittin interactions with adenylate cyclase","volume":"498","author":"Cook","year":"1977","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cpt.2025.03.005_bib148","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0006-2952(94)90037-X","article-title":"Inhibition of protein kinase C by melittin: antagonism of binding interactions between melittin and the catalytic domain by active-site binding of MgATP","volume":"47","author":"Gravitt","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.005_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1155622","article-title":"A review on nanoparticles: characteristics, synthesis, applications, and challenges","volume":"14","author":"Altammar","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cpt.2025.03.005_bib150","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: a lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.005_bib151","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3892\/mmr.2017.6970","article-title":"Melittin exerts an antitumor effect on non-small cell lung cancer cells","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.cpt.2025.03.005_bib152","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40360-021-00503-z","article-title":"In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria","volume":"22","author":"Askari","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cpt.2025.03.005_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12645-021-00085-9","article-title":"Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect","volume":"12","author":"Dabbagh Moghaddam","year":"2021","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.cpt.2025.03.005_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107769","article-title":"Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells","volume":"50","author":"Giribaldi","year":"2021","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cpt.2025.03.005_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.cpt.2025.03.005_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102869","article-title":"State-of-the-art advancement of surface functionalized layered double hydroxides for cell-specific targeting of therapeutics","volume":"314","author":"Khalili","year":"2023","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.cpt.2025.03.005_bib157","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.actbio.2016.01.035","article-title":"High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells","volume":"33","author":"Rai","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cpt.2025.03.005_bib158","doi-asserted-by":"crossref","first-page":"S1226","DOI":"10.1080\/21691401.2018.1536063","article-title":"Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC\u2013MS\/MS","volume":"46","author":"Hematyar","year":"2018","journal-title":"Artif Cells, Nanomed Biotechnol"},{"key":"10.1016\/j.cpt.2025.03.005_bib159","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1080\/21691401.2018.1449118","article-title":"Role of gold and silver nanoparticles in cancer nano-medicine","volume":"46","author":"Chugh","year":"2018","journal-title":"Artif Cells, Nanomed Biotechnol"},{"key":"10.1016\/j.cpt.2025.03.005_bib160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/toxins13020147","article-title":"Cell-penetrating peptides derived from animal venoms and toxins","volume":"13","author":"R\u00e1dis-Baptista","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.824989","article-title":"Mastoparans: a group of multifunctional \u03b1-helical peptides with promising therapeutic properties","volume":"9","author":"de Santana","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cpt.2025.03.005_bib162","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.3390\/polym13234225","article-title":"Mastoparan, a peptide toxin from wasp venom conjugated fluvastatin nanocomplex for suppression of lung cancer cell growth","volume":"13","author":"Alhakamy","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.cpt.2025.03.005_bib163","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14789450.5.5.731","article-title":"Proteome and peptidome profiling of spider venoms","volume":"5","author":"Liang","year":"2008","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.cpt.2025.03.005_bib164","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/toxins8050119","article-title":"The spider venom peptide lycosin-II has potent antimicrobial activity against clinically isolated bacteria","volume":"8","author":"Wang","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib165","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/toxins2122851","article-title":"Spider-venom peptides as therapeutics","volume":"2","author":"Saez","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib166","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1021\/acs.jpcb.5b12618","article-title":"Quantifying the distribution of the stoichiometric composition of anticancer peptide Lycosin-I on the lipid membrane with single molecule spectroscopy","volume":"120","author":"Tan","year":"2016","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.cpt.2025.03.005_bib167","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1039\/c8tx00022k","article-title":"Anticancer, antimicrobial, and analgesic activities of spider venoms","volume":"7","author":"Akef","year":"2018","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.cpt.2025.03.005_bib168","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.1021\/acs.jmedchem.9b01126","article-title":"Position effect of fatty acid modification on the cytotoxicity and antimetastasis potential of the cytotoxic peptide lycosin-I","volume":"62","author":"Zhang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib169","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/acs.biomac.8b01138","article-title":"Polymer-based nanomaterials for photothermal therapy: from light-responsive to multifunctional nanoplatforms for synergistically combined technologies","volume":"19","author":"Pierini","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cpt.2025.03.005_bib170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114207","article-title":"Pharmacology and therapeutic potential of venom peptides","volume":"181","author":"Robinson","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.005_bib172","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/toxins12050326","article-title":"Scorpion toxins and ion channels: potential applications in cancer therapy","volume":"12","author":"Due\u00f1as-Cuellar","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib173","series-title":"Black seeds (Nigella sativa): pharmacological and therapeutic applications","first-page":"253","article-title":"Chapter 11 - black seeds of Nigella sativa: a remedy for advanced cancer therapeutics with special reference to nanotechnology","author":"Ahmada","year":"2022"},{"key":"10.1016\/j.cpt.2025.03.005_bib174","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.toxicon.2013.08.064","article-title":"Venom proteomic and venomous glands transcriptomic analysis of the Egyptian scorpion Scorpio maurus palmatus (Arachnida: Scorpionidae)","volume":"74","author":"Abdel-Rahman","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.cpt.2025.03.005_bib175","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cpt.2025.03.005_bib176","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.cpt.2025.03.005_bib177","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jocn.2016.04.012","article-title":"Glioblastoma multiforme targeted therapy: the chlorotoxin story","volume":"33","author":"Cohen-Inbar","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.cpt.2025.03.005_bib178","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijpharm.2018.09.033","article-title":"Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: a nanotechnological approach","volume":"551","author":"Agarwal","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cpt.2025.03.005_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104998","article-title":"Chlorotoxin binds to both matrix metalloproteinase 2 and neuropilin 1","volume":"299","author":"Farkas","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib180","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/cancers15133388","article-title":"Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles","volume":"15","author":"Boltman","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.cpt.2025.03.005_bib181","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.gt.3302238","article-title":"Gene therapy progress and prospects: cancer gene therapy using tumor suppressor genes","volume":"11","author":"McNeish","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.cpt.2025.03.005_bib182","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.cpt.2025.03.005_bib183","series-title":"Systems of nanovesicular drug delivery","first-page":"239","article-title":"Chapter 15 \u2013 nanophytosomes: a novel approach for the delivery of herbal drugs","author":"Martins-Gomes","year":"2022"},{"key":"10.1016\/j.cpt.2025.03.005_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100962","article-title":"Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents","volume":"48","author":"Kopp","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.cpt.2025.03.005_bib185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cpt.2025.03.005_bib186","article-title":"Advances in the use of chitosan and chlorotoxin-functionalized chitosan polymers in drug delivery and detection of glioma \u2013 a review","volume":"7","author":"Wiranowska","year":"2024","journal-title":"Carbohydr Polym Technol Appl"},{"key":"10.1016\/j.cpt.2025.03.005_bib187","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1021\/nn503735w","article-title":"Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors","volume":"8","author":"Stephen","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.cpt.2025.03.005_bib188","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/am5092165","article-title":"Temozolomide nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Fang","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cpt.2025.03.005_bib189","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10989-020-10117-4","article-title":"C-terminal amidation of chlorotoxin does not affect tumor cell proliferation and has no effect on toxin cytotoxicity","volume":"27","author":"Ayed","year":"2021","journal-title":"Int J Pept Res Therapeut"},{"key":"10.1016\/j.cpt.2025.03.005_bib190","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/biomedicines10102605","article-title":"A conjugate between Lqh-8\/6, a natural peptide analogue of chlorotoxin, and doxorubicin efficiently induces glioma cell death","volume":"10","author":"Dardevet","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cpt.2025.03.005_bib191","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J Contr Release"},{"key":"10.1016\/j.cpt.2025.03.005_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965882","article-title":"Bioactive peptides from venoms against glioma progression","volume":"12","author":"Majc","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.03.005_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.662064","article-title":"CAR T cell-based immunotherapy for the treatment of glioblastoma","volume":"15","author":"Maggs","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cpt.2025.03.005_bib194","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jconrel.2020.07.003","article-title":"A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer","volume":"326","author":"Jain","year":"2020","journal-title":"J Contr Release"},{"key":"10.1016\/j.cpt.2025.03.005_bib195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10544-008-9209-0","article-title":"Nanotechnology for breast cancer therapy","volume":"11","author":"Tanaka","year":"2009","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.cpt.2025.03.005_bib196","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.leu.2402064","article-title":"New agents for induction and postremission therapy of acute myeloid leukemia","volume":"15","author":"Larson","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cpt.2025.03.005_bib197","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nano.2006.04.005","article-title":"Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties","volume":"2","author":"Nijhara","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cpt.2025.03.005_bib198","doi-asserted-by":"crossref","DOI":"10.1177\/11795514211006071","article-title":"Therapeutic potential of peptides derived from animal venoms: current views and emerging drugs for diabetes","volume":"14","author":"Coulter-Parkhill","year":"2021","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.cpt.2025.03.005_bib199","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib201","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/nn700048y","article-title":"In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos","volume":"1","author":"Lee","year":"2007","journal-title":"ACS Nano"},{"key":"10.1016\/j.cpt.2025.03.005_bib202","series-title":"Nanotechnologies for the life sciences: online","article-title":"Nanoparticles and nanowires for cellular engineering","author":"Winter","year":"2007"},{"key":"10.1016\/j.cpt.2025.03.005_bib203","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/0008-5472.CAN-07-6102","article-title":"Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent","volume":"68","author":"Patra","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpt.2025.03.005_bib204","article-title":"Biodegradable and renal clearable inorganic nanoparticles","volume":"3","author":"Ehlerding","year":"2016","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cpt.2025.03.005_bib205","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.cpt.2025.03.005_bib206","article-title":"Monodispersed copper (I)-based nano metal-organic framework as a biodegradable drug carrier with enhanced photodynamic therapy efficacy","volume":"6","author":"Cai","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cpt.2025.03.005_bib207","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40643-024-00805-0","article-title":"Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy","volume":"11","author":"El-Qassas","year":"2024","journal-title":"Bioresour Bioprocess"},{"key":"10.1016\/j.cpt.2025.03.005_bib208","first-page":"39","article-title":"Evaluating the toxicity of selected types of nanochemicals","author":"Kumar","year":"2012","journal-title":"Rev Environ Contam Toxicol"},{"key":"10.1016\/j.cpt.2025.03.005_bib209","first-page":"61","article-title":"Influence of nanotoxicity on human health and environment: the alternative strategies","volume":"242","author":"Viswanath","year":"2017","journal-title":"Rev Environ Contam Toxicol"},{"key":"10.1016\/j.cpt.2025.03.005_bib210","first-page":"281","article-title":"A computer model for the simulation of nanoparticle deposition in the alveolar structures of the human lungs","volume":"3","author":"Sturm","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cpt.2025.03.005_bib211","series-title":"Nanobiomaterials science, development and evaluation","first-page":"261","article-title":"14 - safety, regulatory issues, long-term biotoxicity, and the processing environment","author":"Razavi","year":"2017"},{"key":"10.1016\/j.cpt.2025.03.005_bib212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smim.2017.09.011","article-title":"Effects of engineered nanoparticles on the innate immune system","volume":"34","author":"Liu","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cpt.2025.03.005_bib213","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.fbp.2016.02.003","article-title":"Bioprocess challenges to the isolation and purification of bioactive peptides","volume":"98","author":"Agyei","year":"2016","journal-title":"Food Bioprod Process"},{"key":"10.1016\/j.cpt.2025.03.005_bib214","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","article-title":"Peptides as multifunctional players in cancer therapy","volume":"55","author":"Vadevoo","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cpt.2025.03.005_bib215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10989-024-10588-9","article-title":"Diving into the venom apparatus transcriptomes of Pterois antennata and Pterois radiata: unearthing a novel genus-specific Piscidin-3 homolog and a multifarious repertoire of antimicrobial peptides","volume":"30","author":"Prajapati","year":"2024","journal-title":"Int J Pept Res Therapeut"},{"key":"10.1016\/j.cpt.2025.03.005_bib216","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbamem.2004.12.004","article-title":"The interactions of antimicrobial peptides derived from lysozyme with model membrane systems","volume":"1668","author":"Hunter","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cpt.2025.03.005_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1465459","article-title":"Venom-derived peptides for breaking through the glass ceiling of drug development","volume":"12","author":"Freuville","year":"2024","journal-title":"Front Chem"},{"key":"10.1016\/j.cpt.2025.03.005_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.811365","article-title":"Structural and functional diversity of animal toxins interacting with GPCRs","volume":"9","author":"Van Baelen","year":"2022","journal-title":"Front Mol Biosci"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:24:24Z","timestamp":1773505464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713225000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":218,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2949713225000357"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2025.03.005","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arthropod venom peptides: Nanotechnology-enabled delivery and therapeutic potential in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}